31 search results for: coexisting diseases

slide presentation

Type 2 Inflammation and Infections

15 min

Type 2 Inflammation

This slide deck will provide an overview of the concepts of type 1, type 2, and type 3 immune responses.

expert video

Overview of Prurigo Nodularis Part 2: Burden of Disease and Considerations of Patient Care

5 min

Dermatology

Join Dr. Matt Zirwas as he uncovers the burden of prurigo nodularis and highlights considerations for patient care in the second part of this discussion.

expert video

It Takes a Village: Patient-Centered Care in Pediatric EoE

2 min

Gastroenterology

Learn from Prof. Papadopoulou as she highlights the importance of collaboration of multiple specialties in the care of pediatric EoE.

expert video

Importance of Early Diagnosis of Pediatric EoE

4 min

Gastroenterology

Learn from Prof. Papadopoulou as she highlights challenges in identifying EoE in pediatric patients and the consequences of delayed diagnosis.

videoanimation

EoE Burden and Pathophysiology of Type 2 Inflammation

3 min

Gastroenterology

Learn about the significant burden that patients with EoE experience, and the role of type 2 inflammation in this chronic, progressive disease.

expert video

Scientific Advances in EoE and Impact on Clinical Practice

30 min

Gastroenterology

Expert gastroenterologist Dr. Evan Dellon highlights research and scientific advances in EoE and their impact on clinical practice.

expert video

Long-term Impacts of AD and the Potential Benefit of Early Intervention

2 min

Dermatology

In this highlight video from the March 2024 AD symposium, Dr. Lawrence Eichenfield discusses the potential importance of early intervention in pediatric patients, and how addressing AD at an early stage may stop the clock on associated systemic comorbidities in the long term.

expert video

Practical Considerations in Older Patients with AD

21 min

Dermatology

This video from the March 2024 ADVENT AD symposium features Dr. Katrina Abuabara presenting on practical considerations in older patients with AD. Dr. Abuabara elaborates on several unique challenges faced by older adult patients with AD, including differential diagnoses and age-dependent clinical factors and decisions relevant to their disease management. She goes on to discuss the concept of “inflamm-aging” as it relates to systemic inflammatory markers and associated comorbidities in older adult patients, followed by a brief panel discussion.

expert video

The Cumulative Disease Burden of AD in Adult Patients

3 min

Dermatology

In this highlight video from the March 2024 AD symposium, Dr. Eric Simpson discusses the array of allergic and non-allergic comorbidities that may impact adult patients with AD and how the cumulative burden of these comorbidities contributes to reduced quality of life. He goes on to discuss the potential for addressing the multimorbidities related to AD through early intervention before they have the opportunity to develop or progress.

expert video

Role of Type 2 Inflammation in Prurigo Nodularis Part 1: Overview of Type 2 Inflammation

8 min

Dermatology

Join Dr. Raj Chovatiya as he provides an overview of the impact of type 2 inflammation in prurigo nodularis in the first part of this discussion.

expert video

Type 2 Inflammation: A Common Link Between Atopic Dermatitis and Prurigo Nodularis

10 min

Dermatology

In this ADVENT symposium at the 2024 Diversity in Dermatology conference, Dr(s) Sarina Elmariah and Mona Shahriari engage in a dynamic discussion on how clinical signs and itch in atopic dermatitis and prurigo nodularis are impacted by type 2 inflammation.

expert video

Role of Type 2 Inflammation in Prurigo Nodularis Part 2: Itch and Skin Lesions

13 min

Dermatology

Dive deeper into the specific role of type 2 inflammation in neuroimmune dysregulation and dermal fibrosis that leads to itch and skin lesions seen in patients with prurigo nodularis with Dr. Raj Chovatiya in the second part of this discussion.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region